Loratadine Redidose

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 23 USDMF, 12 CEP/COS, 6 JDMF, 15 EU WC, 16 KDMF, 13 NDC API, 24 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

34 Intermediate Suppliers

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

295 FDF Dossiers, 61 FDA Orange Book, 116 Europe, 13 Canada, 5 Australia, 42 South Africa, 58 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 5MG;120MG, TABLET, EXTENDED RELEASE;ORAL - 10MG;240MG, SYRUP;ORAL - 1MG/ML, TABLET, ORALLY DISINTEGRATING;ORAL - 10MG, CAPSULE;ORAL - 10MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 5 Rochem International Inc, 23 SPI Pharma, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 8 Kirsch Pharma, 1 Panvo Organics, 1 Cerata Pharmaceuticals LLP, 17 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 28 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 2 Gloria Interchem, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 2 JJ Chemicals, 20 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 43 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 39 Thickeners and Stabilizers, 37 Direct Compression, 35 Taste Masking, 33 Granulation, 30 Disintegrants & Superdisintegrants, 30 Solubilizers, 27 Controlled & Modified Release, 27 Parenteral, 26 Lubricants & Glidants, 24 Chewable & Orodispersible Aids, 24 Film Formers & Plasticizers, 23 Topical, 16 Co-Processed Excipients, 15 API Stability Enhancers, 9 Emulsifying Agents, 9 Empty Capsules, 5 Rheology Modifiers, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 29 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 Regulatory FDF Prices

16 Regulatory FDF Prices

MARKET PLACE

46 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 37 Others

Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21952 / DOSAGE - CAPSULE;ORAL - 10MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LORATADINE(UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN)	LORATADINE	10mg \| 10mg

Inactive Ingredients

Ingredient Name	CHAIN DRUG MARKETING ASSOCIATION INC.	TopCare	Cardinal Health	Bayer HealthCare LLC.	TARGET CORPORATION
CAPRIC ACID(4G9EDB6V73)
CAPRYLIC/CAPRIC MONO/DIGLYCERIDES(U72Q2I8C85)
FD&C BLUE NO. 1(H3R47K3TBD)
GELATIN(2G86QN327L)
GLYCERIN(PDC6A3C0OX)
GLYCERYL MONO- AND DICAPRYLOCAPRATE(U72Q2I8C85)
POLYSORBATE 80(6OZP39ZG8H)
POVIDONE K30(U725QWY32X)
POVIDONE(FZ989GH94E)
SORBITAN(6O92ICV9RU)
SORBITOL(506T60A25R)
WATER(059QF0KO0R)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Setid 8e14b61f Faf6 43a8 A080 75f64514217a Applno 21952 Form Capsule Oral Dosage 10mg - Drug Product Composition: Loratadine Redidose